Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

9.53

+0.05 (0.53%)

At close: May 9, 2025, 4:00 PM

9.53

0.00 (0.00%)

After-hours: May 9, 2025, 4:00 PM EDT

Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	May '25 May 9, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	893	1,038	1,967	-
Market Cap Growth	-51.60%	-47.22%	-	-
Enterprise Value	865	1,050	1,946	-
Last Close Price	9.53	12.10	25.69	-
PE Ratio	214.49	85.93	-	-
PS Ratio	8.13	9.82	17.34	-
PB Ratio	12.07	10.55	25.07	-
P/TBV Ratio	14.17	16.85	-	-
P/FCF Ratio	-	-	113.23	-
P/OCF Ratio	-	-	75.99	-
EV/Sales Ratio	8.60	9.93	17.15	-
EV/EBITDA Ratio	72.14	58.96	95.72	-
EV/EBIT Ratio	82.93	64.73	101.27	-
EV/FCF Ratio	-	-	111.99	-
Debt / Equity Ratio	0.02	0.02	0.01	0.01
Debt / EBITDA Ratio	0.12	0.09	0.02	0.06
Debt / FCF Ratio	-	-	0.02	0.11
Asset Turnover	0.80	0.87	1.13	-
Inventory Turnover	0.59	0.73	0.89	-
Quick Ratio	2.65	2.64	2.49	3.33
Current Ratio	3.60	3.32	2.85	4.06
Return on Equity (ROE)	12.12%	20.24%	-113.45%	-
Return on Assets (ROA)	5.18%	8.38%	11.93%	-
Return on Capital (ROIC)	6.69%	11.34%	15.83%	-
Return on Capital Employed (ROCE)	9.40%	15.30%	19.90%	12.70%
Earnings Yield	0.81%	1.16%	-4.72%	-
FCF Yield	-	-0.57%	0.88%	-
Buyback Yield / Dilution	-44.36%	-55.39%	13.02%	-

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q